iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing ... iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc. 詳細を表示
SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody immunotherapies, announced today the appointment of biotech industry veterans...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.04 | 1.63265306122 | 2.45 | 2.55 | 2.3 | 61123 | 2.41803433 | CS |
4 | -0.19 | -7.08955223881 | 2.68 | 2.97 | 2.2401 | 83005 | 2.56114227 | CS |
12 | 0.27 | 12.1621621622 | 2.22 | 3.15 | 2.0646 | 142614 | 2.63013973 | CS |
26 | 0.42 | 20.2898550725 | 2.07 | 3.15 | 1.5 | 104053 | 2.40904159 | CS |
52 | 1.07 | 75.3521126761 | 1.42 | 4.98 | 1.0214 | 1044126 | 3.32338152 | CS |
156 | -10.39 | -80.6677018634 | 12.88 | 73.2 | 1.0214 | 1421282 | 11.05338627 | CS |
260 | -2.11 | -45.8695652174 | 4.6 | 157 | 1.0214 | 6584726 | 37.37906219 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約